PROM1 and triple-negative breast carcinoma: The CSC marker CD133 has been shown to be hyper-methylated in bulk cells compared to the CSC population 73,74, while CD133 and CD44 were shown to be hypomethylated and subsequently overexpressed in triple-negative breast cancer compared to non-triple-negative 72.